Prevalence and Factors Associated with Metabolic Syndrome Among HIV/AIDS Infected Patients Who Use ARV, Nan Province, 2015-1016

Main Article Content

Chantana Teekawong
Tawatchai Apidechkul
Mitra Cassely
Korakot Chansareewittaya

Abstract

Objective: A cross-sectional study design was conducted to assess the prevalence and factors associated with the
metabolic syndrome among HIV/AIDS infected patients in Nan Province, Thailand.
Methods: The study samples were drawn from antiretroviral clinics (ARV) at 10 district hospitals in Nan Province
from 2015-2016, aged ≥18 years, who had received antiretroviral therapy for at least six months.The metabolic
syndrome was assessed using the criteria of the National Cholesterol Education Program-Adult Treatment Panel
III (NCEP ATP III). A validated questionnaire and laboratory analysis were used as research instruments. Logistic
regression was used to identify the associations between variables at alpha=0.5.
Results: 252 HIV/AIDS patients who were on ARV were recruited into the study. 53.2% were males, average age was
41.3 years, 55.6% graduated from secondary school, and 51.9% had income ≤5,000 per month. 65.1% had received
ARV ≥25 months, and 87.7% had a CD4 level ≤ 200 cell/cm3, 23.4% had a high systolic blood pressure, and 29.4% had
a high diastolic blood pressure. 4.0% had high fasting blood glucose, 40.1% had a high triglyceride, 50.4% of males
had a low high density lipoprotein-cholesterol (HDL-cholesterol), and 78.6% of females had a low HDL-cholesterol.
The overall prevalence of metabolic syndrome was 52.8%. After control for all confounding variables, HIV/AIDS
patients aged 41-50 years had a 1.89 times greater chance (95%CI=1.07-3.33) to develop metabolic syndrome
compared to those aged <30 years old, and those aged ≥51years old had a greater chance 2.14 times (95%CI=1.12-
4.53) to develop metabolic syndrome than those aged <30 years old. Those who had no history of taking food more
than three times a day had a 1.96 times greater opportunity to develop metabolic syndrome (95%CI=1.19-3.24).
Conclusion: Thailand needs to set up a surveillance system on metabolic syndrome among HIV/AIDS infected
patients who use ARV to monitor prolonged side effects. Essential health information including personal healthy
dietary behavior should be provided for all ARV receiving patients.

Downloads

Download data is not yet available.

Article Details

How to Cite
Teekawong, C., Apidechkul, T., Cassely, M., & Chansareewittaya, K. (2017). Prevalence and Factors Associated with Metabolic Syndrome Among HIV/AIDS Infected Patients Who Use ARV, Nan Province, 2015-1016. Siriraj Medical Journal, 69(6), 319–329. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/106165
Section
Original Article